1981PubMedRequires access

[Use of pimozide (ORAP) in child psychiatry (author's transl)].

Broche Jp

Open publisher page 3 citations

Abstract

In a double blind cross-over study, pimozide was tested in 10 children with antisocial behavior. During two months, pimozide was administered orally between 1 and 2,6 mg per day. The use of a behavior scale permitted to conclude that pimozide improves social integration in the Socio-familial milieu.

About this research paper

What this paper is about

In a double blind cross-over study, pimozide was tested in 10 children with antisocial behavior. During two months, pimozide was administered orally between 1 and 2,6 mg per day. The use of a behavior scale permitted to conclude that pimozide improves social integration in the Socio-familial milieu.

Why it matters

OpenAlex reports 3 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

In a double blind cross-over study, pimozide was tested in 10 children with antisocial behavior. During two months, pimozide was administered orally between 1 and 2,6 mg per day. The use of a behavior scale permitted to conclude that pimozide improves social integration in the Socio-familial milieu.

Key concepts: Pimozide, Psychiatry, Medicine, Psychology, Internal medicine, Haloperidol, Dopamine

Related papers

Back to paper searchBrowse research topicsOriginal source
[Use of pimozide (ORAP) in child psychiatry (author's transl)]. — Research Paper | ScholarLens